Clinical Trials Browser

Phase 2 × Colorectal Neoplasms, Hereditary Nonpolyposis × Nivolumab × Clear all

NCT03631641 2024-07-01

Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy

Phase 2 Terminated

3 enrolled 5 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis